Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Primary Myelofibrosis 41Myeloproliferative Disorders 30Polycythemia Vera 28Myelodysplastic Syndromes 15Leukemia, Myeloid, Acute 13Thrombocythemia, Essential 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Neoplasms 7Myelodysplastic-Myeloproliferative Diseases 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia 6Hematologic Diseases 5Thrombocytosis 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Bone Marrow Diseases 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Monocytic, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Graft vs Host Disease 2Breast Neoplasms 2Blast Crisis 2Anemia 2

Interventions

venetoclax 1ruxolitinib 1parsaclisib 1CA-4948 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Sensory and Autonomic Neuropathies × ruxolitinib × Myeloid × Clear all
NCT02718300 2024-05-01

A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis

Incyte Corporation

Phase 2 Terminated
74 enrolled 40 charts
Myeloid

Myeloproliferative Disorders, Hereditary Sensory and Autonomic Neuropathies, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡